Esperoct® keeps factor levels at or above 3% (moderate hemophilia) for 100% of the time in people 12 years or older who treat prophylactically.d,e,f
![Extended half-life Extended half-life](/content/dam/biopharm/esperoct/home/1-0-hero-extended half-life.png)
![Extended half-life Extended half-life](/content/dam/biopharm/esperoct/home/1-0-hero-extended half-life.png/_jcr_content/renditions/mobile)
What does it mean for you?
Esperoct® is an injectable extended half-life (EHL) for hemophilia A. Compared with standard half-life products it may require fewer infusions and offers higher factor levels.
![Extended half-life](/content/dam/biopharm/esperoct/home/1-0-hero-extended half-life.png)
![Extended half-life](/content/dam/biopharm/esperoct/home/1-0-hero-extended half-life.png/_jcr_content/renditions/mobile)
What does it mean for you?
Esperoct® is an injectable extended half-life (EHL) for hemophilia A. Compared with standard half-life products it may require fewer infusions and offers higher factor levels.
![High factor levels](/content/dam/biopharm/esperoct/home/1-0-hero-high factor levels.png)
for longer.
![Factor levels at or above 3% graphic](/content/dam/biopharm/esperoct/home/1-0-stat-100.png)
A switch from standard half-life treatment to Esperoct® means factor levels remain high from one dose to the next.
dFactor activity between 1%-5% is defined as moderate hemophilia.
eTrough level goal is 1% for prophylaxis.
fData shown are from a study where 175 previously treated adolescents and adults received routine prophylaxis with Esperoct® 50 IU/kg every 4 days for 76 weeks. Pre-dose factor activity (trough) levels were evaluated at follow-up visits. Mean trough levels for adolescents (12-<18 years) were 2.7 IU/dL.
![Stay protected](/content/dam/biopharm/esperoct/home/1-0-stay protected.png)
from bleeds.
Headline
In the main phase of the pivotal trial for adults and adolescents, results show 1.2 ABR overall bleeds per year, 0.9 joint bleeds per year, and 0 spontaneous/traumatic bleeds.g After being treated with Esperoct® for up to 6.6 years, people 12 years and older in the long-term trial, including main and extension phases, saw an overall bleed rate of 0.8 per year.h
![Long-term trial results](/content/dam/biopharm/esperoct/home/1-0-0.8 graphic.png)
g175 PTPs with severe hemophilia A received Esperoct® 50 IU/kg every 4 days for 76 weeks based on median annualized bleed rates shown.
hMedian annualized bleeding rate shown is from the main and extension phases of the pivotal clinical trial of previously treated people aged ≥12 years with severe hemophilia A who received Esperoct® 50 IU/kg every 4 days, for up to 6.6 years.
![Esperoct®](/content/dam/biopharm/esperoct/home/1-0-esperoct can take heat.png)
can take the heat.
With Esperoct®, factor can be stored from 86˚F up to 104˚F for up to 3 months, opening the door to more of life's adventures.i
![Mountains Mountains](/content/dam/biopharm/esperoct/home/1-0-can take heat illustration.png)
ior 86˚F for up to 12 months and up to 4 hours after reconstitution.
![Esperoct® package and syringe Esperoct® medication](/content/dam/biopharm/esperoct/home/1-0-hero-box-shot-test.jpg)
![Man thinking with a thought bubble above his head](/content/dam/biopharm/esperoct/home/1-0-personality quiz illustration.png)
Take the
treatment personality quiz!
![](/content/dam/biopharm/esperoct/spanish/global/global-hr-line-green.png)
Do you love a good plan? Or seeing where the road takes you? Your answer may help you find ways to manage hemophilia A that work best for you. Take our quiz to discover your “treatment personality type”!
Set up your
Infusion Reminder Calendar
![](/content/dam/biopharm/esperoct/home/1-0-line-white-gradient.png)
Keep track of your Esperoct® infusion schedule with this easy-to-use reminder tool. Just click the “add a reminder” link and pick your start date to add a reminder that goes straight to your computer or phone.
Switch to
dosing made simple.
![](/content/dam/biopharm/esperoct/global/global-hr-line-green.png)
A standard 50 IU/kg dose makes
starting or switching to Esperoct® easy.
Get the
support you need.
![](/content/dam/biopharm/esperoct/global/global-hr-line-green.png)
Struggling with insurance issues, connecting to community, or getting the product information you need? Here are resources that can help.
![Woman speaking on a headset](/content/dam/biopharm/esperoct/home/1-0-support beyond treatement.png)